Bailard’s Sabra Healthcare REIT SBRA Stock Holding History

Bailard’s Portfolio SBRA Stock Details SBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,692	Closed	-$975K	–	842
2026 Q1	$975K	Buy	50,692 +3,972	+9%	+$78.2K	0.02%	327
2025 Q4	$885K	Sell	46,720 -1,300	-3%	-$24.1K	0.02%	341
2025 Q3	$895K	Buy	48,020 +1,300	+3%	+$24.3K	0.02%	345
2025 Q2	$862K	Hold	46,720	–	–	0.02%	349
2025 Q1	$816K	Buy	46,720 +33,383	+250%	+$563K	0.02%	339
2024 Q4	$231K	Sell	13,337 -1,345	-9%	-$24.6K	0.01%	658
2024 Q3	$273K	Hold	14,682	–	–	0.01%	618
2024 Q2	$226K	Hold	14,682	–	–	0.01%	643
2024 Q1	$217K	Buy	+14,682	New	+$203K	0.01%	669
2022 Q3	–	Sell	-24,020	Closed	-$336K	–	748
2022 Q2	$336K	Buy	+24,020	New	+$321K	0.01%	455
2022 Q1	–	Sell	-37,025	Closed	-$501K	–	802
2021 Q4	$501K	Buy	+37,025	New	+$524K	0.02%	407
2020 Q4	–	Sell	-15,100	Closed	-$208K	–	675
2020 Q3	$208K	Buy	+15,100	New	+$222K	0.01%	460
2020 Q1	–	Sell	-22,700	Closed	-$484K	–	554
2019 Q4	$484K	Buy	+22,700	New	+$508K	0.03%	290

Other funds holding SBRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIM

Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bailard's SBRA Position: Q2 2026 in Review

Bailard sold out of Sabra Healthcare REIT (SBRA) in Q2 2026, closing a stake of 50,692 shares — an estimated $975K sold.

Bailard first reported a position in SBRA in Q4 2019 and held it in 13 quarters. The position peaked at $975K in Q1 2026. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

Bailard reported no remaining Sabra Healthcare REIT position as of Q2 2026 after selling out during the quarter.
Bailard sold 50,692 Sabra Healthcare REIT shares in Q2 2026, an estimated $975K.
Bailard first reported a position in Sabra Healthcare REIT in Q4 2019 and held it in 13 quarters.
Bailard's Sabra Healthcare REIT position peaked at $975K in Q1 2026.
464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.